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University, Budapest, HungaryObjective: To clarify the effects of dihydrotestosterone (DHT)–induced polycystic ovary syndrome (PCOS) on the insulin-dependent
vasodilatation of the thoracic aorta and the role of vitamin D in a rat model.
Design: Controlled experimental animal study.
Setting: Laboratory.
Animal(s): Thirty adolescent female Wistar rats.
Intervention(s): The PCOS model was induced by 10 weeks of DHT treatment (83 mg/d). One-half of the DHT-treated animals also
received vitamin D (120 ng/kg/wk).
Main Outcome Measure(s): The aortic rings of the control, DHT, and DHT plus vitamin D–treated animals were isolated. The insulin-
dependent vasodilation of the isolated aortic rings was compared in Krebs-Ringer solution and under blockade of nitric oxide (NO)
synthase or cyclooxygenase.
Result(s): The insulin-dependent vasorelaxation decreased in both DHT-treated groups independently from the vitamin D treatment;
NO-dependent and -independent relaxations were both impaired. In response to prostanoid, vasoconstriction was increased after DHT
treatment. The NO-independent relaxation was partially improved by vitamin D treatment, which was neutralized by increased
prostanoid-dependent vasoconstriction.
Conclusion(s): Previously, we found that vitamin D treatment prevented systemic insulin resistance; however, in this study, we did notUse your smartphonedetect any inﬂuence on the vascular insulin resistance of the aorta that was induced by DHT
treatment. Consequently, controlling insulin resistance with vitamin D alone did not resolve
the aortic endothelial dysfunction caused by the hyperandrogenic state. (Fertil Steril
2013;99:573–8. 2013 by American Society for Reproductive Medicine.)
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VOL. 99 NO. 2 / FEBRUARY 2013C ertain metabolic changes, suchas hyperinsulinemia, insulinresistance, and metabolic syn-
drome, may already be present before
the onset of polycystic ovary syndrome
(PCOS) and may in fact mediate the on-
set of PCOS (1, 2). Type 2 diabetes
mellitus and the risk for cardiovascular
diseases develop earlier in the majority
of women with PCOS than in the
general population (1, 2). In the present
study, we examined early functional
changes in large blood vessels, most573
ORIGINAL ARTICLE: REPRODUCTIVE BIOLOGYlikely the earliest detectable difference, Manneras et al.
developed a reliable experimental model to study PCOS (3).
Chronic treatment of adolescent female rats with
dihydrotestosterone (DHT) induces a PCOS-like condition, in-
cluding impaired insulin sensitivity (3, 4).
The insulin resistance that occurs in PCOS can be re-
versed by insulin sensitizers such as metformin (5). Metfor-
min decreases serum glucose and insulin levels.
Furthermore, metformin has beneﬁcial effects on the cardio-
vascular system. Agarwal et al. have proved that metformin
reduces arterial stiffness and improves endothelial function
in young women with PCOS (6). Palomba et al. and Naka
et al. showed the enhancement of ﬂow-mediated dilatation
and of vascular endothelial function by metformin (7, 8).
At the same time, vitamin D use has emerged as an
adjuvant therapy in PCOS (9). Vitamin D therapy
has positive effects on carbohydrate metabolism (10, 11)
and has been suggested to prevent cardiovascular
complications as well (12, 13). Therefore, we investigated
the effects of protective doses of vitamin D in
hyperandrogenic female (HAF) rats. A similar chronic
vitamin D therapy prevented heart failure and left
ventricular hypertrophy in adolescent heart failure–prone
spontaneously hypertensive rats (SHR) (13). Previously, we
reported that after 70 days of DHT administration, the
insulin-induced vasorelaxation decreased in the small ar-
teries of HAF rats (14). This effect was prevented by a con-
comitant weekly dosage of vitamin D. Because nitric oxide
(NO)–dependent relaxation, which deteriorated with chronic
DHT treatment, was not inﬂuenced by vitamin D, other
mechanisms of compensation might be involved. In the
present study, we aimed to clarify the effects of DHT on
the insulin-dependent vasodilatation of the aortic rings of
HAF rats and the possible modulatory role of a protective
dose of vitamin D. To conﬁrm these effects, we examined
NO-dependent relaxation in the aortic rings as well as the
possible role of prostanoids in the compensatory mecha-
nism. In this study, we tested the two essential mechanisms
regulating vascular tone: the relaxing capacity under pre-
treatment with L-NG-nitroarginine methyl ester hydrochlo-
ride (L-NAME, i.e., NO synthase blocker) or indomethacin
(i.e., cyclooxygenase blocker). Earlier, we demonstrated the
positive effect of vitamin D on systemic insulin resistance
(14). The DHT-dependent reduction of insulin-induced vaso-
relaxation found in small arteries was improved by parallel
vitamin D administration (14). We sought to demonstrate
a similar phenomenon in large vessels, such as the aorta,
in a HAF rat model.METHODS
Drugs and Chemicals
The composition of the normal Krebs-Ringer (nKR) solu-
tion used in the in vitro studies was (in mmol/L) 119
NaCl, 4.7 KCl, 2.5 CaCl2$2H2O, 1.17 MgSO4$7H2O, 20
NaHCO3, 1.18 KH2PO4, 0.027 EDTA, and 11 glucose (Sigma
Aldrich). The solution was maintained at 37C and
aerated with 5% CO2 and 95% O2, which stabilized the
pH at 7.4.574Norepinephrine, acetylcholine chloride, 17b-estradiol,
L-NAME, and indomethacin were obtained from Sigma-
Aldrich. Human recombinant insulin (100 NE/mL Actrapid
Penﬁll) was obtained from Novo Nordisk. The drugs were
freshly prepared in nKR solution on the day of the
experiment.
Animals
Thirty adolescent 21–28-day-old female Wistar rats weighing
100–140 g were used (Semmelweis University Animal Colony,
Budapest, Hungary; originated from Charles River). Experi-
mental polycystic ovary syndrome was achieved as described
by Manneras et al. (3), with the use of 90-day continuous-
release pellets containing 7.5 mg DHT (Innovative Research
of America; daily dose 83 mg). Ten animals underwent sham
operations (control group). The rats were anesthetized with
pentobarbital (Nembutal; Phylaxia-Sanoﬁ) during surgical
interventions. Following chronic surgical interventions, 20
mg amoxicillin þ 4 mg clavulanic acid (Augmentin; Glaxo
Smith Kline) dissolved in 0.2 mL saline solution was adminis-
tered intramuscularly to prevent infections. Ten DHT-treated
animals received 120 ng/100 g body wt./wk of 1,25(OH)2-vi-
tamin D3 (DHTþD3 group). The vitamin D was given subcuta-
neously as previously described by Przybilski et al. We
administered a weekly—for 10 weeks—instead of daily dosage
(13, 14) of vitamin D to reduce the stress to the animals.
1,25(OH)2-vitamin D3 was chosen (injectable Calcijex, 2 mg/
mL; Abbott Laboratories) because this is the active form of
vitamin D and the action of other forms depends on liver
and renal function (13, 14). The control group and ten of
the DHT-treated animals received vitamin D vehicle (saline
solution) subcutaneously. As described earlier, after 8 weeks
of treatment, the oral glucose tolerance test (OGTT) was per-
formed in short ether narcosis to assess glucose homeostasis
(fasting and 120-minute blood glucose and plasma insulin
levels were measured after the administration of 20 mg glu-
cose/100 g body weight, in gauge) (14). The fasting glucose
and insulin levels were similar in all groups. At the 120-
minute time point of the OGTT, the insulin level measured
in the DHT-treated rats was three times higher than in both
the control and the DHTþD3-treated animals (14). A signiﬁ-
cant difference between the fasting and the 120-minute insu-
lin levels was found only in the DHT group (14), which
developed insulin resistance after DHT treatment (14). Vita-
min D treatment prevented insulin elevation (14). The serum
fructoseamine level was similar in all groups and within the
reference range, indicating that the animals did not have
diabetes or elevated blood glucose (14). The ovaries of the
animals were collected and immediately ﬁxed for histologic
examinations to determine whether polycystic morphology
was present as described earlier (14). No medical or surgical
complications were observed. Conventional rat chow
(S8106-S011 SMR/M-ZþH, with physiologic vitamin D con-
tent; Spezialdi€aten) and tap water were provided ad libitum.
The study conformed to the Guide for the Care and Use of Lab-
oratory Animals published by the U.S. National Institutes of
Health and was approved by the Institutional Animal Care
Commission (Institutional Review Board approval 22.1/
2960/003/2009).VOL. 99 NO. 2 / FEBRUARY 2013
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Aortic Rings
After opening the chest, the deeply anesthetized animals were
transcardially perfused with 10 mL heparinized (10 IU/mL)
nKR solution. After perfusion, the heart and aorta of each animal
were removed, and theheartswereweighed. Thedistal part of the
thoracic aorta (TA) was isolated, and four rings were prepared
andplaced into avessel chamberﬁlledwithnKRsolutionaerated
with carbogen (95% O2 balanced with 5% CO2; Lindegas).
Segments of the thoracic aorta of 3 mm length from each
experimental group were mounted on the stainless steel vessel
holders (200 mm diameter) of a conventional myograph setup
(610-M Multi Myograph System; Danish Myo Technology).
The organ chambers of the myographs were ﬁlled with 8 mL
nKR solution. The bath was warmed to 37C, and the resting
tension of the TA rings was adjusted to 15 mN, as described in
previous studies (15, 16).
The segments were exposed to 124 mmol/L Kþ to elicit
a reference contraction. Twenty minutes later, precontraction
was induced by norepinephrine (5 x 108 mol/L), and endothe-
lial relaxation was tested using 108–105 mol/L acetylcho-
line. After recovery, the insulin-mediated vasorelaxation was
tested by the administration of increasing concentrations of in-
sulin (50–150–300–600 mU/mL) in precontracted (5 x 108
mol/L norepinephrine) vessels. Afterward, the vascular rings
were incubated with either 104 mol/L indomethacin or 104
mol/L L-NAME for 20 minutes, and the insulin dose-response
measurement was repeated to test different potential pathways
of relaxation. Indomethacin blocks the synthesis of all prosta-
noids (including prostacyclin and thromboxane), and L-NAME
is a general inhibitor of NO synthases (all three forms). Between
measurements, the vessels were rinsed and allowed a 20-
minute-long recovery period. Aortic relaxations were tested
after a stable plateau of contraction had been reached. The re-
laxant responses were expressed as a percentage of the precon-
traction produced by norepinephrine.
The isometric tension of the TA segments was recorded
with a MP100 system, and the recorded data were analyzed
with Acq-Knowledge 3.7.3 software (Biopac Systems). Vaso-
active substances were dissolved in physiologic saline solu-
tion (0.9 v/v% NaCl). All concentrations are expressed as
the ﬁnal concentration in the organ bath. NO-dependent vas-
orelaxation was counted as a relative difference in insulin-
related direct and L-NAME–induced relaxations.Histology
The ovaries of the animals were collected and freshly ﬁxed for
histologic examinations. The tissue samples were immersion
ﬁxed in 4% buffered formaldehyde and examined with the
use of light microscopy (hematoxylin-eosin staining; Pannor-
amic viewer software was used for evaluation; 3D Histech).
The ovaries were examined for controlling polycystic mor-
phology as described earlier (12).Statistical Analysis
The dose-tension curves were analyzed by repeated-measures
analysis of variance (ANOVA). The discrete parameters wereVOL. 99 NO. 2 / FEBRUARY 2013analyzed statistically by one-way ANOVA. The Newman-
Keuls test was applied for post hoc analysis. P< .05 was
uniformly accepted as signiﬁcantly different. The data are
presented as mean  SEM.
RESULTS
Basic Parameters of the Animals
At the end of the experiments, the body weights of the ani-
mals were 298 8 g, 354 16 g, and 353 9 g for the control
(C) and DHT- and DHTþD3–treated groups, respectively (14).
The body weight was higher after the DHT treatment, inde-
pendently from vitamin D coadministration (P< .05 for both
C vs. DHT and C vs. DHTþD3, nonsigniﬁcant for DHT vs.
DHTþD3) (14). After 10 weeks, there was no signiﬁcant differ-
ence in the blood pressures of the groups, as measured directly
by carotid artery cannulation: 122  3 mm Hg, 123  6 mm
Hg, and 123  4 mm Hg for the control group, the DHT-
treated group, and the DHTþD3–treated group, respectively
(nonsigniﬁcant) (14). From histologic analysis, polycystic
ovaries were found in the DHT-treated groups and normal
ovaries in the control group. Multiple premature cysts were
detected peripherally without dominant follicles in the
DHT-treated animals. The follicle diameters were signiﬁcantly
smaller in the DHT-treated ovaries than in the control (1,609
 617 and 2,334  451 pixels at 40 magniﬁcation, respec-
tively; P< .05). The diameters of the follicles of the DHTþD3
ovaries were not signiﬁcantly different from those of the
other two groups (2,054  442 pixels).Insulin-Induced Relaxation of Aortic Rings
The insulin-induced relaxation was signiﬁcantly lower in the
DHT-treated groups than in the control group (Fig. 1; P< .05
for C vs. DHT and C vs. DHTþD3). The D3 treatment had no
signiﬁcant effect on the insulin-induced aortic relaxation.
The L-NAME incubation signiﬁcantly reduced the insulin-
induced relaxation in the control rats. For the entire dose range,
the insulin-induced relaxation after L-NAMEpreincubationwas
also reduced in the DHT-treated rats compared with the control
rats (Fig. 2A; P< .01 for C vs. DHT; P< .05 for C vs. DHTþD3). A
repeated-measures ANOVA revealed that vitamin D treatment
improved insulin-induced relaxation after L-NAME incubation
overall (P< .05 DHT vs. DHTþD3). Figure 2B shows the NO-
dependent portion of the relaxation of the different groups
upon insulin challenge. The DHT-treated groups were different
from the control groups (for both comparisons: P< .001) but
not from each other (DHT vs. DHTþD3: ns).
The insulin-induced relaxation was also reduced by
indomethacin. After indomethacin incubation, the insulin-
induced relaxation curves were also impaired in the DHT-
treated rats (Fig. 3; P< .05 for C vs. DHT and C vs. DHTþD3).
Again, vitamin D treatment was able to improve the insulin-
induced vasorelaxation in the DHT-treated animals at doses
of 150–600 mIU/mL.
DISCUSSION
In our previous study, we demonstrated that vitamin D
therapy reversed systemic insulin resistance in our early575
FIGURE 1
Insulin-induced vascular relaxation in the treatment and control
groups. Line graphs show the concentration-response curves of the
insulin-induced vascular relaxation of aortic rings obtained from the
normal control rats compared with the DHT-treated and DHT and
vitamin D3–treated rats. The ordinate shows relaxation as
a percentage of the contractions induced by norepinephrine (5 x
108 mol/L). Each data point represents the mean  SEM from 40
rings. P<.05 for *C vs. DHT and yC vs. DHTþD3. There was no
difference between the DHT-treated groups. These data suggest
that insulin-induced vascular (aortic) relaxation is impaired in the
DHT-treated rats and that vitamin D3 is not able to improve that
relaxation.
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the OGTT in the DHT-treated animals was nearly threefold
higher than in the control animals. The vitamin D supplemen-
tation completely reversed the insulin resistance. Similar re-
sults were observed after insulin-dependent vasorelaxation
of small arteries (14).
In the present study, we aimed to clarify the detailed
mechanism for the deterioration of the insulin-dependent
vasorelaxation of aortic rings. We demonstrated that DHT
treatment reduced the insulin-dependent relaxation of rat
aortic rings. This loss of insulin-dependent dilation is the
vascular manifestation of insulin resistance. In contrast to
systemic insulin resistance and local insulin-dependent
relaxation in small vessels, i.e., arterioles, the net effect of
vitamin D treatment on vascular insulin resistance caused
by a hyperandrogenic state was neutral in the aortic rings.
A similar dissociation of the metabolic and vascular insulin
resistance has been demonstrated for aging (17), which proves
that such dissociation is not without precedence. Because the
effects of vitamin D on micro- and macrovessels differed (14;
this study), it is possible that the remaining direct effect of
chronic DHT treatment impaired large vessel wall reactivity.
Vitamin D had no signiﬁcant impact on the insulin-induced
vasorelaxation in the aorta of DHT-treated rats; however,
vitamin D was protective to insulin-induced relaxation in
arterioles, and this may be related to elimination of systemic
insulin resistance in DHT-treated rats (14). The explanation of576this could be a change in vasodilation mechanisms associated
with insulin in different vessel types.
As suggested by a recent publication (18), a key mecha-
nism of insulin-dependent vasorelaxation is the activation
of the NO pathway. In accordance with this ﬁnding, our study
showed that blocking the NO pathway by L-NAME decreased
vasorelaxation in the control aortas. Our results suggest that
the DHT treatment caused a decline in the insulin-dependent
relaxation principally through deterioration of the NO-
dependent relaxation. The remaining relaxation after the
NO pathway was blocked, demonstrating that other relaxa-
tion pathways participate in this process. The vitamin D treat-
ment limited the deterioration of the NO-independent (in the
presence of L-NAME) insulin relaxation induced by the DHT
treatment; however, the vitamin D treatment did not alter
the NO pathway signiﬁcantly (Fig. 2).
Earlier studies demonstrated mild vasorelaxant effects of
the cyclooxygenase inhibitor indomethacin on the aorta (19);
those ﬁndings are consistent with our observations of a mod-
erate enhancement of vasorelaxation in the aortas of all
groups. Interestingly, after indomethacin pretreatment the
loss of insulin-dependent vasorelaxation by DHT was par-
tially reversed by vitamin D. Thus, indomethacin diminished
the constrictor tone of aortas, which was stronger in the
DHTþD3 group than in the DHT-alone group (Fig. 3.). Previ-
ously, Keller et al. (20) described an increase in prostanoid-
dependent vasoconstriction in resistance vessels in a similar
90-day DHT-induced rat model of PCOS. In our study, a fur-
ther increase was found in prostanoid vasoconstriction after
concomitant vitamin D application.
Considering these results, we suggest that the local effect
of vitamin D treatment is a partial increase in NO-
independent relaxation and an increase in constrictor prosta-
noid effects. However, the lack of effect of vitamin D on
insulin vasorelaxation without pretreatment suggests the in-
volvement of other, unknown, relaxation effects, such as
endothelium-derived hyperpolarizing factor (21) or other
mechanisms. Concomitantly with improving glucose metab-
olism (22, 23), plasma NO responsiveness might be elevated
after vitamin D treatment (21), which may balance this effect.
Long-term systemic insulin resistance is accompanied
by vessel damage and atherosclerosis (24, 25); however,
controlling insulin resistance by vitamin D treatment alone
did not resolve the vascular damage to the aorta caused by
the hyperandrogenic state in our model. The DHT-induced
model of PCOS in rats has been demonstrated to resemble
human PCOS in that polycystic ovaries develop and andro-
gen levels are elevated threefold (3, 4) after 8–12 weeks of
DHT treatment. The direct effects of the hyperandrogenic
state on blood vessels should be taken into account.
Malkin et al. have shown that acute testosterone treatment
induced vasodilation, whereas chronic treatment decreased
endothelium-dependent and endothelium-independent vas-
orelaxation and increased norepinephrine-induced vaso-
constriction (26). Gonzales et al. described an increase
in thromboxane-induced tone after testosterone pretreat-
ment (27).
The effects of vitamin D on vessel function have been
studied. The acute application of vitamin D decreasedVOL. 99 NO. 2 / FEBRUARY 2013
FIGURE 2
Insulin-induced vascular relaxation after incubation with L-NAME in the treatment and control groups. (A) Insulin-induced relaxation after L-NAME
incubation was signiﬁcantly larger in the control group than in the DHT-treated groups for the entire dose-relaxation curve (*P<.01 for C vs. DHT;
yP<.05 for C vs. DHTþD3). However, repeated-measures analysis of variance revealed that vitamin D3 treatment improved overall insulin-induced
relaxation after L-NAME incubation. The relaxation of aortic rings wasmore pronounced in the DHTþD3 animals than in the DHT group (zP<.05). (B)
The NO-dependent portion of the relaxation on the insulin dose-response curve for the different groups. The DHT-treated groups were different
from the control group (for both comparisons: *,yP<.001) but not from each other (DHT vs. DHTþD3: ns).
Masszi. Effects of insulin on the aorta in PCOS. Fertil Steril 2013.
Fertility and Sterility®prostanoid-dependent vasoconstriction in SHR to the level of
the control Wistar Kyoto rats by weakening the endothelium-
dependent 6-keto-prostaglandin F1a–mediated vasoconstric-
tion in the SHR (12).FIGURE 3
Insulin-induced vascular relaxation after incubation with indomethacin
in the treatment and control groups. Insulin-induced relaxation
following indomethacin incubation was signiﬁcantly larger in
the control than in the DHT-treated groups for the entire dose-
relaxation curve (P<.05 for *C vs. DHT and yC vs. DHTþD3). For
doses from 150 mIU/mL to 600 mIU/mL, vessels from the DHTþD3
animals relaxed more than those from the DHT-only animals (zP<.05).
Masszi. Effects of insulin on the aorta in PCOS. Fertil Steril 2013.
VOL. 99 NO. 2 / FEBRUARY 2013Furthermore, it has been demonstrated that 6-week vita-
min D treatment normalized the enhanced acetylcholine-
dependent relaxation in SHR; this enhancement was not
related to the intracellular Ca balance but correlated with
the decreased amounts of reactive oxidative free radicals
and cyclooxygenase-1 expression (12). Currently, there is
no other information available relating the effect of vitamin
D to vascular prostanoid metabolism. However, Wong et al.
described a prostanoid-dependent relaxation (12) that is in
contradiction to the vasoconstrictor effect we found. The
variation in the effect of vitamin D may be explained by the
differences in the examined vessels or species or may be the
consequence of an interaction between the effect of vitamin
D and increased prostanoid constriction caused by DHT treat-
ment (20). When studying the vascular effects of vitamin D in
hyperandrogenic females, we have to consider the direct vas-
cular effects of vitamin D, interactions with DHT, and indirect
vascular effects on improving systemic insulin resistance.
However, the latter effect was not dominant in the rat aorta
in terms of insulin-dependent relaxation.
Based on these studies, in clinical conditions we have to
count the balancing effects of vitamin D in PCOS-related vas-
cular damage. Drugs used in PCOS affect vascular function;
they might deteriorate or improve it (28). It is important to
know the net effects and potential interactions all of the drugs
used to start optimal therapy for our patients.
CONCLUSION
This study is the ﬁrst to show a decreased insulin-dependent
relaxation effect in the aorta after DHT treatment. Vitamin D577
ORIGINAL ARTICLE: REPRODUCTIVE BIOLOGYsupplementation helped to avoid elevation of the serum
insulin levels (14) but did not change the decrease in the
insulin-dependent relaxation in the rat aorta. The diminished
relaxation caused by the androgenic effect was partially NO
dependent. The net neutral effect of vitamin D on the rat aorta
might be explained by the balance between the local constric-
tor prostanoids and a moderate alteration of the NO-
independent relaxation; these effects have not been studied
yet. In this study, we tested the two most important mecha-
nisms that lead to normal (control) vascular tone; however,
testing other mechanisms will be necessary in the future.
This is the ﬁrst study to note the possibility of a different dom-
inance of the same mechanisms and different levels of vascu-
lar damage for similar stimuli in micro- and macrovessels;
these differences suggest possible mechanisms with timing
differences in target-organ damage.
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